68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Abbott Laboratories market cap

Abbott Laboratories volume of trade today and historical data of Abbott Laboratories capitalization since start date of trade of ABT stocks.
Add to widgets
Added to widgets

Abbott Laboratories capitalization

Today's market capitalization for Abbott Laboratories is 155 530 117 120 US dollar.
+3 157 884 928 $ (+2.07%)
change of capitalization since yesterday

Abbott Laboratories volume of trade

Today's Abbott Laboratories volume of trade is 1 811 413 US dollar.
-212 343 $ (-10.49%)
change of volume of trade since yesterday
Show:
to

Abbott Laboratories market cap chart

Week Month 3 months Year 3 years

Abbott Laboratories capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
19/07/2019 155 530 117 120 $
18/07/2019 152 372 232 192 $
17/07/2019 152 160 518 144 $
16/07/2019 146 709 217 280 $
15/07/2019 147 855 917 056 $
12/07/2019 148 150 403 072 $
11/07/2019 151 234 330 624 $

Abbott Laboratories volume chart

Week Month 3 months Year 3 years

Abbott Laboratories volume history data

Date Volume (24h)
Volume of trade of Abbott Laboratories - total sum in US dollars for all deals with ABT stocks bought and sold during selected date.
19/07/2019 1 811 413 $
18/07/2019 2 023 756 $
17/07/2019 1 360 832 $
16/07/2019 3 866 831 $
15/07/2019 4 591 902 $
12/07/2019 3 431 876 $
11/07/2019 1 377 576 $

Abbott Laboratories capitalization is 155 530 117 120 $ now. Market capitalization of Abbott Laboratories changed by +2.07% since yesterday. Today's volume of trade of ABT stocks was 1 811 413 $. ABT volume of trade amount changed to -10.493% since yesterday.

Abbott Laboratories stocks data

Abbott Laboratories financials